Results 71 to 80 of about 11,591 (182)

Anti-protozoal Activity of Conifer Green Needle Complex against

open access: yesNatural Product Communications, 2019
Treatment of Trichomonas vaginalis typically involves using nitroimidazoles (such as metronidazole and tinidazole). Some T. vaginalis strains have become resistant to these drugs, so the development of new drugs is necessary.
Lidia B. Kulyashova   +3 more
doaj   +1 more source

Sexually and non‐sexually transmitted infections and the risk of prostate cancer: Results from the EPICAP study

open access: yesCancer Medicine
Introduction Prostate cancer (PCa) is by far the most common type of cancer among men in western countries. However, relatively little is known about its etiology despite the high morbidity and mortality.
Melissa Sawaya   +5 more
doaj   +1 more source

Investigation of the frequency and relationship between trichomonas infection in the preterm delivery (a case-control study in Amir Al-Momenin Hospital, Semnan)

open access: yesJournal of Family Medicine and Primary Care
Introduction and Purpose: Preterm delivery is a common complication during pregnancy periods and imposes a high cost on the healthcare system due to the care needs of premature babies.
Elham Saffarieh   +3 more
doaj   +1 more source

Differential Drug Susceptibility across Trichomonasvirus Species Allows for Generation of Varied Isogenic Clones of Trichomonas vaginalis

open access: yesPathogens
Trichomonas vaginalis (Tvag) is a sexually transmitted human pathogen that is commonly infected with strains of one or more of five known species of Trichomonas vaginalis viruses (TVVs), members of genus Trichomonasvirus.
Carrie A. Hetzel   +3 more
doaj   +1 more source

Alpha-Pinene and Tannic Acid Inhibit Trichomonas vaginalis Protozoan Cells by Inducing Apoptosis

open access: yesIranian Journal of Parasitology
Background: Trichomoniasis is one of the most common sexually transmitted infections worldwide. The growing concern of drug resistance of this infection has cautioned the need for new drug development.
Masoumeh Moradi   +4 more
doaj  

Urticaria from Trichomonas vaginalis infection.

open access: yesJournal of investigational allergology & clinical immunology, 1999
We report the case of a 32-year-old woman who had pruritic urticarial skin lesions associated with episodes of arthralgia. The first site affected by the eruption was the inside surface of the thighs; the patient also reported the presence of leukorrhea. The woman had previously been treated with H1 antagonist with moderate and transitory results; skin
PURELLO D'AMBROSIO F   +6 more
openaire   +2 more sources

Nitazoxanide and tizoxanide demonstrate high levels of in vitro activity against metronidazole-susceptible and metronidazole-resistant Trichomonas vaginalis clinical isolates

open access: yesMicrobiology Spectrum
Trichomonas vaginalis is the most common non-viral sexually transmitted infection worldwide. We compared the in vitro activity of the thiazolide nitazoxanide (NTZ) and its metabolite, tizoxanide (TIZ), with the activity of the Food and Drug ...
Keonte J. Graves   +5 more
doaj   +1 more source

Factors influencing the Prevalence and pathogenicity of Trichomonas vaginalis

open access: yesمجلة كلية الطب, 2007
Background: Trichomonas vaginalis is a common parasite of both male and female genital tracts. Transmission of the infection is mainly by sexual intercourse; however contaminated towels, douche equipments, examination instruments and other objects may be
Aroub Abdul Rahman Al-Kaisi   +2 more
doaj  

Persistent trichomoniasis in a man in his early 90s with a history of prostatic hyperplasia: A case report

open access: yesJournal of International Medical Research
The protozoan Trichomonas vaginalis is a parasite associated with numerous sexually transmitted infections worldwide. In males, although Trichomonas vaginalis infection (also known as trichomoniasis) often remains asymptomatic, it can lead to conditions ...
Mahdi Fakhar   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy